X
More than 60,000 patients use Brite
4.6 stars
Your health finally understandable with Brite
1
Enter email and you're done. No subscription, no credit card.
2
Search, tap and you're done. Over 3,400 medicines.
3
Check, remind, get an overview.
Sarah K., 34
I finally understand my therapy. The app reminds me, answers my questions — and I don't feel alone with it anymore.
Celecoxib belongs to the coxibs — anti-inflammatory painkillers that block the enzyme COX-2 specifically and largely leave the stomach-protecting COX-1 alone. Because of that, stomach ulcers and bleeding occur less often than under classic NSAIDs such as ibuprofen or diclofenac. The price of this advantage is the cardiovascular question: before any longer course of treatment there is therefore an honest weighing up of benefit and risk.
See more detail.gif)
How long you have been taking it, your blood pressure and your other medicines in one place — free in the brite app.
| Property | Details |
|---|---|
| Active ingredient | Celecoxib |
| ATC code | M01AH01 |
| Drug class | Non-steroidal anti-inflammatory drug (NSAID) from the coxib group — a selective COX-2 inhibitor |
| Dosage forms | Hard capsules, usually in strengths of 100 mg and 200 mg |
| Half-life | Around 8 to 12 hours — taken once or twice daily depending on the indication |
| Maximum daily dose | Depending on the indication, as a rule up to 400 mg daily; what always governs is the lowest effective dose |
| Onset of effect | Pain relief usually within a few hours; the full anti-inflammatory effect often only after one to two weeks |
| Prescription status | Prescription-only medicine |
| Notable feature | Markedly fewer stomach ulcers and upper gastrointestinal bleeds than classic NSAIDs; in exchange, strict restrictions where there is cardiovascular disease |
To understand celecoxib you only need one idea: there are two variants of the same enzyme, and classic painkillers switch both of them off. The enzyme is called cyclooxygenase, COX for short. It produces messenger substances that convey pain, inflammation and fever — but also ones that protect the stomach and regulate the blood flow through the kidneys. It comes in two forms:¹
Classic NSAIDs such as ibuprofen or diclofenac inhibit both forms. The inflammation goes down — but so does the protection of the stomach. That is exactly where stomach pain, ulcers and bleeding under these drugs come from. Celecoxib blocks COX-2 preferentially: the anti-inflammatory and pain-relieving effect is retained, while COX-1, and with it the protective mechanism of the stomach lining, is largely left undisturbed. That is the great advantage of this group of drugs — and it is well documented.²
A second difference: celecoxib barely inhibits the platelets. It does not "thin the blood" in the sense that aspirin does — and it does not replace a prescribed anticoagulant.
Celecoxib is not an all-purpose painkiller for the household medicine cabinet; it is licensed for inflammatory and degenerative joint diseases — where anti-inflammatory treatment is needed over a longer period.
The typical reason for choosing this particular drug is an increased stomach risk: previous ulcers, a bleed in the history, older age, or an accompanying treatment that puts strain on the stomach. For acute everyday pain without an inflammatory component celecoxib is usually not the drug of choice — which group fits when is set out in the guide painkillers compared, and where joint pain comes from in the matching symptom article.
The details below describe the usual approach according to the SmPC. They are not a dosing instruction — the dose and the duration are set by the treating practice.
Above everything stands one principle from the safety assessments of the regulatory authorities: the lowest effective dose, for as short a time as possible.³ That is not an empty phrase — both the stomach risk and the cardiovascular risk rise with the dose and with the duration of use.
Your duration of use and your blood pressure over time, documented — the basis for the next weighing up of benefit and risk.
Celecoxib is better tolerated in the gastrointestinal tract than classic NSAIDs — that does not make it free of complaints. The typical side effects follow directly from the mechanism.
The decisive question is not "which NSAID is the best?" but "which risk weighs more heavily in my case?". The four commonest drugs differ above all in where their weak spot lies.
| Active ingredient | Gastrointestinal risk | Cardiovascular risk | Kidneys & blood pressure | Typical role |
|---|---|---|---|---|
| Celecoxib | The most favourable of the four: markedly fewer ulcers and upper gastrointestinal bleeds | Increased; strict restrictions where cardiovascular disease is present | As with all NSAIDs: a rise in blood pressure and strain on the kidneys are possible | Where the stomach risk is in the foreground and the heart is unremarkable |
| Ibuprofen | Moderate, dose-dependent | Comparatively favourable at a low dose, increased at a high dose | A rise in blood pressure and strain on the kidneys are possible | The standard for short-term use |
| Diclofenac | Moderate to increased | Assessed as the least favourable of the classic NSAIDs | A rise in blood pressure and strain on the kidneys are possible | Effective, but used more sparingly because of the cardiac risk |
| Naproxen | Increased, particularly with long-term treatment | Regarded as the most favourable NSAID in cardiovascular terms | A rise in blood pressure and strain on the kidneys are possible | Preferred where the cardiovascular risk is in the foreground |
From that follows the rule of thumb that the authorities put the same way: the choice depends on the individual risk profile.³ A stomach ulcer in your history speaks for celecoxib — with gastric protection where appropriate. If a heart condition is in the foreground, that speaks against a coxib. Where both come together, the right answer is often not NSAID treatment at all, but a different route.
This is the section that distinguishes celecoxib from a "simply better tolerated ibuprofen". The assessments of the European regulatory authorities have drawn clear limits for the coxibs, and they are set out that way in the SmPC too.¹,³
Even without these diagnoses, restraint applies where several risk factors come together: high blood pressure, raised blood lipids, type 2 diabetes and smoking. Then — if at all — the dose is kept particularly low and the treatment particularly short, and the need for it is reviewed regularly.
So that no panic arises here: this is about a relative increase in risk, which for the individual person with a healthy cardiovascular system stays small and which grows with dose and duration. The message is not "celecoxib is dangerous", but "not permanently and unmonitored — and where heart disease is present, not at all".
A widespread misunderstanding goes: coxibs spare not only the stomach but the kidneys as well. That is not the case. The kidney uses COX-2 to regulate its blood flow and for salt and water excretion — exactly the enzyme that celecoxib inhibits. In terms of kidney risk, coxibs therefore barely differ from classic NSAIDs.¹
Celecoxib is broken down predominantly by the liver enzyme CYP2C9. The relevant combinations follow from that and from the NSAID-typical effect on the kidneys and the stomach.
| Combination | Consequence | What to do |
|---|---|---|
| Low-dose aspirin for vascular protection | Celecoxib's stomach advantage is partly lost, because aspirin inhibits COX-1 | Review the combination critically; if it is continued, additional gastric protection often makes sense |
| Phenprocoumon and other vitamin K antagonists | An increased tendency to bleed; the INR can rise | Close INR checks, particularly in the first few weeks and after every dose change |
| Direct oral anticoagulants and antiplatelet drugs | A markedly increased risk of bleeding in the gastrointestinal tract | Only after careful weighing up, usually with gastric protection |
| ACE inhibitors, sartans, diuretics | The blood-pressure-lowering effect is weakened, kidney function can suffer | Check blood pressure and kidney values; avoid the triple combination |
| Other NSAIDs, over-the-counter ones included | No additional benefit, added stomach and kidney risk | Do not combine |
| Certain antidepressants (SSRIs) and corticosteroid preparations such as prednisolone | An increased risk of gastrointestinal bleeding | Consider gastric protection, know the warning signs |
| CYP2C9 inhibitors and alcohol | The celecoxib level can rise; alcohol irritates the stomach lining | Have a dose adjustment checked, cut down on alcohol |
The most important point is in the first row and is often overlooked: anyone taking low-dose aspirin daily for vascular protection loses part of celecoxib's stomach advantage. Aspirin blocks COX-1 irreversibly for the lifetime of the platelets — so the protective mechanism that celecoxib deliberately leaves alone is switched off from the other side. That does not make the combination wrong, but it changes the calculation on which the choice of drug rests. On alcohol, see medications and alcohol.
At first sight it sounds contradictory: a stomach-friendly NSAID — and then gastric protection on top of it? In certain situations that is exactly the safest option, because the residual risk is not zero: with previous stomach or duodenal ulcers, with the simultaneous use of aspirin, anticoagulants, corticosteroids or certain antidepressants, and in older age with prolonged use.
What is usual then is a proton pump inhibitor such as pantoprazole, given alongside for the duration of the NSAID treatment and reviewed afterwards — gastric protection left over from a pain treatment that ended long ago is a classic case for a medication review.
Celecoxib contains a sulfonamide group in its chemical structure. That is why the SmPC lists a contraindication for people with a known hypersensitivity to sulfonamides, and why the question comes up regularly in the pharmacy.¹
To put it in perspective: the much-discussed "sulfonamide allergy" usually refers to sulfonamide antibiotics, which are chemically built differently from celecoxib. A genuine cross-reaction is regarded, on current knowledge, as unlikely, but it is not ruled out with certainty. In practice that means: a known intolerance of sulfonamides must be mentioned — the decision is made by the prescribing practice. Anyone who has had a severe skin reaction to a medicine in the past should raise that as well.
In older age several things come together: kidney function declines, the gastrointestinal risk rises, cardiovascular disease is commoner, and several medicines are usually being taken side by side. NSAIDs are therefore scrutinised particularly critically in older age — and if they are used, then at a low dose, for a limited time and with an eye on blood pressure and kidney values: medications in old age.
In the last third of pregnancy, NSAIDs including celecoxib are contraindicated. The reason is concrete: they can cause the premature closure of an important blood vessel (the ductus arteriosus) in the unborn child, impair the child's kidney function and reduce the amount of amniotic fluid; on top of that they can delay the birth.⁴ In the first two thirds as well, NSAIDs are used only where there is a clear need, and celecoxib is not the drug of choice there, because considerably more experience is available with other substances. Guidance is offered by medications during pregnancy — the decision is always made by the practice looking after you.
With impaired liver function celecoxib is broken down more slowly, which is why a reduced dose is provided for with moderate impairment and it is not used with severe impairment. The same applies with advanced kidney weakness. Anyone with one of these conditions should mention it with every new prescription — including for over-the-counter painkillers.
If "cannot tolerate" means stomach complaints, then often yes — that is exactly what this group of drugs was developed for. Two qualifications: the stomach advantage does not replace a cardiovascular check, and where heart disease is present celecoxib is not an option. And if "cannot tolerate" meant an allergic reaction or an asthma attack, then caution is called for, because reactions of that kind can occur across the NSAID group. Describe precisely what happened back then.
There is no fixed figure that applies to everyone — but there is an attitude: for as short a time as possible, and reviewed at set intervals. In osteoarthritis, use during phases of complaints is often more sensible than taking it continuously. With inflammatory rheumatic diseases a longer course can be necessary — then with regular checks of blood pressure, kidney values and symptoms. The only wrong thing is to let it run on unnoticed for years.
Yes, and more than many people think. Low-dose aspirin permanently inhibits COX-1 in the platelets — that is to say, precisely the mechanism that celecoxib deliberately spares. The stomach advantage is partly cancelled out as a result, and the risk of bleeding rises. That is no reason to stop the aspirin yourself, under any circumstances, because it protects you against vascular events. The right step is to assess the combination together with your practice — frequently gastric protection is then added, or the choice of drug is thought through again.
With NSAIDs there is no withdrawal problem; stopping is possible without tapering. What can come back are the complaints — and that is precisely the useful information. Anyone who stops after a complaint-free phase and watches what happens often finds that treatment in flares is enough. It makes sense to agree this with your practice and to note down how things go, rather than doing it quietly. On the general approach: stopping medications.
The interaction check shows critical combinations before you take them.
How long you have been taking it, your blood pressure over time and an interaction check in one place. Free.
Create medication plan